KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Inventory (2016 - 2026)

Emergent BioSolutions has reported Inventory over the past 17 years, most recently at $327.6 million for Q1 2026.

  • For Q1 2026, Inventory rose 4.33% year-over-year to $327.6 million; the TTM value through Mar 2026 reached $327.6 million, up 4.33%, while the annual FY2025 figure was $343.4 million, 10.17% up from the prior year.
  • Inventory for Q1 2026 was $327.6 million at Emergent BioSolutions, down from $343.4 million in the prior quarter.
  • Over five years, Inventory peaked at $528.2 million in Q3 2022 and troughed at $311.7 million in Q4 2024.
  • A 5-year average of $357.4 million and a median of $343.4 million in 2025 define the central range for Inventory.
  • Biggest five-year swings in Inventory: surged 44.87% in 2022 and later plummeted 32.96% in 2023.
  • Year by year, Inventory stood at $350.7 million in 2022, then fell by 6.22% to $328.9 million in 2023, then dropped by 5.23% to $311.7 million in 2024, then grew by 10.17% to $343.4 million in 2025, then dropped by 4.6% to $327.6 million in 2026.
  • Business Quant data shows Inventory for EBS at $327.6 million in Q1 2026, $343.4 million in Q4 2025, and $356.3 million in Q3 2025.